AL 8697
AL 8697 is a specific and orally active p38α MAPK inhibitor with an IC50 of 6 nM. AL 8697 displays 14-fold greater inhibition of p38α compared to p38β (IC50=82 nM), and 300-fold selectivity for p38α over a panel of 91 kinases. Anti-inflammatory activity[1].
Product Specifications
CAS Number
[1057394-06-5]
UNSPSC
12352005
Target
Autophagy; p38 MAPK
Type
Reference compound
Related Pathways
Autophagy; MAPK/ERK Pathway
Applications
Neuroscience-Neuromodulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/al-8697.html
Purity
99.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1CC1)C2=CC(F)=C(C)C(C3=C(F)C4=NN=C(C(C)(C)C)N4C=C3F)=C2
Molecular Formula
C21H21F3N4O
Molecular Weight
402.41
References & Citations
[1]Balagué C, et al. Profiling of dihydroorotate dehydrogenase, p38 and JAK inhibitors in the rat adjuvant-induced arthritis model: a translational study. Br J Pharmacol. 2012 Jun;166 (4) :1320-32.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
P38α; p38β
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034380-FITC 200 µL
CXCL11, CT (CXCL11, ITAC, SCYB11, SCYB9B, C-X-C motif chemokine 11, Beta-R1, H174, Interferon gamma-inducible protein 9, Interferon-inducible T-cell alpha chemoattractant, Small-inducible cytokine B11) (FITC) discontinued
Ask
View Details 
MBS7135746-01 0.02 mg (Mammalian-Cell)
Recombinant Human T-cell antigen CD7 (CD7), partial
Ask
View Details MBS7135746-02 0.1 mg (Mammalian-Cell)
Recombinant Human T-cell antigen CD7 (CD7), partial
Ask
View Details 
MBS7135746-03 1 mg (Mammalian-Cell)
Recombinant Human T-cell antigen CD7 (CD7), partial
Ask
View Details